Personalizing electroconvulsive therapy for better outcomes in older adults with depression
Electroconvulsive therapy amplitude titration for improved clinical outcomes in late-life depression
This study is looking at how changing the strength of electroconvulsive therapy (ECT) can help older adults with depression feel better while reducing any memory issues, making the treatment more tailored to their needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of New Mexico Health Scis Ctr NIH-funded |
| Lab location | 1 site (Albuquerque, United States) |
| Project ID | NIH-11010854 on NIH RePORTER |
What this research studies
This research investigates how adjusting the intensity of electroconvulsive therapy (ECT) can improve treatment outcomes for older adults suffering from depression. Currently, ECT uses a fixed intensity that may not be suitable for everyone, especially considering the anatomical differences in older patients. By personalizing the amplitude of ECT, the study aims to enhance its effectiveness while minimizing cognitive side effects. The approach involves measuring how changes in amplitude affect brain plasticity and mood improvement.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 50 and above who are experiencing depression and may benefit from electroconvulsive therapy.
Not a fit: Patients who are younger than 50 or those who do not have depression may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer ECT treatments for older adults with depression.
How similar studies have performed: Previous research has shown that personalized approaches in ECT can lead to improved outcomes, suggesting that this method may be effective.
Where this research is happening
Albuquerque, United States
- University of New Mexico Health Scis Ctr — Albuquerque, United States (Active)
Researchers
- Principal investigator: Abbott, Christopher C — University of New Mexico Health Scis Ctr
- Study coordinator: Abbott, Christopher C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.